In light of the FTC’s recent enforcement actions to curb non-competes and its proposed Notice of Proposed Rulemaking that would ban virtually all non-competes, this article provides a historical over…
We provide a summary of the comments submitted by different stakeholders on the Draft Merger Guidelines issued by the Agencies in July 2023.
Analysis of FTC and DOJ’s proposed changes to HSR filings relating to document identification and submission requirements.
This article discusses most-favored-entry clauses in patent settlement agreements between brand and generic drug manufacturers. It explains why many such clauses cause no harm to competition and ins…